↓ Skip to main content

Proteasome Inhibitors Prevent the Degradation of Familial Alzheimer’s Disease-Linked Presenilin 1 and Potentiate Aβ42 Recovery from Human Cells

Overview of attention for article published in Molecular Medicine, March 1998
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Proteasome Inhibitors Prevent the Degradation of Familial Alzheimer’s Disease-Linked Presenilin 1 and Potentiate Aβ42 Recovery from Human Cells
Published in
Molecular Medicine, March 1998
DOI 10.1007/bf03401912
Pubmed ID
Authors

Philippe Marambaud, Karine Ancolio, Elvira Lopez-Perez, Frédéric Checler

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 6%
United Kingdom 1 3%
South Africa 1 3%
Unknown 29 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 15%
Student > Ph. D. Student 4 12%
Professor > Associate Professor 4 12%
Student > Master 4 12%
Professor 3 9%
Other 7 21%
Unknown 6 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 24%
Medicine and Dentistry 4 12%
Neuroscience 4 12%
Biochemistry, Genetics and Molecular Biology 3 9%
Psychology 2 6%
Other 4 12%
Unknown 8 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2004.
All research outputs
#4,778,982
of 23,106,934 outputs
Outputs from Molecular Medicine
#188
of 1,155 outputs
Outputs of similar age
#4,343
of 32,162 outputs
Outputs of similar age from Molecular Medicine
#4
of 13 outputs
Altmetric has tracked 23,106,934 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,155 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 32,162 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.